WallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Forecast, Predictions & Price Target

Analyst price target for TEVA

Based on 1 analysts offering 12 month price targets for Teva Pharmaceutical Industries Ltd.
Min Forecast
$11.00+34.47%
Avg Forecast
$11.00+34.47%
Max Forecast
$11.00+34.47%

Should I buy or sell TEVA stock?

Based on 2 analysts offering ratings for Teva Pharmaceutical Industries Ltd.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

TEVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Bottom 13%
13
HoldDowngradesN/AN/A2021-10-28
Wells Fargo
HoldMaintains$11.00+34.47%2021-07-29
UBS
Top 36%
65
HoldDowngrades$11.00+34.47%2021-05-04

1 of 1

Forecast return on equity

Is TEVA forecast to generate an efficient return?
Company
32.67%
Industry
91.05%
Market
37.5%
TEVA's Return on Equity is forecast to be high in 3 years (32.67%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is TEVA forecast to generate an efficient return on assets?
Company
7.15%
Industry
76.61%
TEVA is forecast to generate lower Return on Assets (7.15%) than the US Drug Manufacturers - Specialty & Generic industry average (76.61%)
Forecast

TEVA earnings per share forecast

What is TEVA's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.51+280.3%
Avg 2 year Forecast
$2.63+298.48%
Avg 3 year Forecast
$2.56+287.88%
TEVA's earnings are forecast to grow at an exceptional rate of 58.83% per year
Forecast

TEVA revenue forecast

What is TEVA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$16.1B-1%
Avg 2 year Forecast
$16.3B+0.45%
Avg 3 year Forecast
$16.4B+1.03%
TEVA's revenue is forecast to grow at a rate of 0.34% per year, which is not exceptional
Forecast

TEVA earnings growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
58.83%
Industry
27.75%
Market
14.37%
TEVA's earnings are forecast to grow faster (58.83% per year) than the US Drug Manufacturers - Specialty & Generic industry average (27.75%)
Forecast
TEVA's earnings are forecast to grow faster (58.83% per year) than the US market average (14.37%)
Forecast
TEVA's earnings are forecast to grow faster (58.83% per year) than the risk-free savings rate (1.4%)
Forecast

TEVA revenue growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
0.34%
Industry
24.29%
Market
10.08%
TEVA's revenues are forecast to grow slower (0.34% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.29%)
Forecast
TEVA's revenues are forecast to grow slower (0.34% per year) than the US market average (10.08%)
Forecast

Teva Pharmaceutical Industries Ltd Stock Forecast FAQ

Is Teva Pharmaceutical Industries Ltd Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: TEVA) stock is to Hold TEVA stock.

Out of 2 analysts, 0 (0%) are recommending TEVA as a Strong Buy, 0 (0%) are recommending TEVA as a Buy, 2 (100%) are recommending TEVA as a Hold, 0 (0%) are recommending TEVA as a Sell, and 0 (0%) are recommending TEVA as a Strong Sell.

What is TEVA's earnings growth forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's forecast annual earnings growth rate of 58.83% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 27.75%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Teva Pharmaceutical Industries Ltd's earnings in 2021 is $726,000,000.On average, 4 Wall Street analysts forecast TEVA's earnings for 2021 to be $2,768,547,992, with the lowest TEVA earnings forecast at $2,691,337,490, and the highest TEVA earnings forecast at $2,823,698,350. On average, 4 Wall Street analysts forecast TEVA's earnings for 2022 to be $2,900,908,852, with the lowest TEVA earnings forecast at $2,757,517,920, and the highest TEVA earnings forecast at $2,989,149,425.

In 2023, TEVA is forecast to generate $2,823,698,350 in earnings, with the lowest earnings forecast at $2,823,698,350 and the highest earnings forecast at $2,823,698,350.

What is TEVA's revenue growth forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's forecast annual revenue growth rate of 0.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 24.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Teva Pharmaceutical Industries Ltd's revenue in 2021 is $16,232,000,000.On average, 5 Wall Street analysts forecast TEVA's revenue for 2021 to be $17,724,936,931,237, with the lowest TEVA revenue forecast at $17,543,329,007,040, and the highest TEVA revenue forecast at $17,911,843,701,869. On average, 5 Wall Street analysts forecast TEVA's revenue for 2022 to be $17,985,308,391,286, with the lowest TEVA revenue forecast at $17,698,654,476,438, and the highest TEVA revenue forecast at $18,295,579,895,616.

In 2023, TEVA is forecast to generate $18,087,874,821,824 in revenue, with the lowest revenue forecast at $17,481,009,102,048 and the highest revenue forecast at $18,426,837,748,608.

What is TEVA's forecast return on assets (ROA) for 2021-2024?

(NYSE: TEVA) forecast ROA is 7.15%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 76.61%.

What is TEVA's Price Target?

According to 1 Wall Street analysts that have issued a 1 year TEVA price target, the average TEVA price target is $11.00, with the highest TEVA stock price forecast at $11.00 and the lowest TEVA stock price forecast at $11.00.

On average, Wall Street analysts predict that Teva Pharmaceutical Industries Ltd's share price could stay at $11.00 by Oct 28, 2022. The average Teva Pharmaceutical Industries Ltd stock price prediction forecasts a potential downside of N/A from the current TEVA share price of $8.18.

What is TEVA's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's current Earnings Per Share (EPS) is $0.66. On average, analysts forecast that TEVA's EPS will be $2.51 for 2021, with the lowest EPS forecast at $2.44, and the highest EPS forecast at $2.56. On average, analysts forecast that TEVA's EPS will be $2.63 for 2022, with the lowest EPS forecast at $2.50, and the highest EPS forecast at $2.71. In 2023, TEVA's EPS is forecast to hit $2.56 (min: $2.56, max: $2.56).

What is TEVA's forecast return on equity (ROE) for 2021-2024?

(NYSE: TEVA) forecast ROE is 32.67%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.